Nicole Kleinstreuer, Thomas Hartung. Artificial intelligence (AI)-it’s the end of the tox as we know it (and I feel fine). Archives of Toxicology. 2024. doi:10.1007/s00204-023-03666-2
Breanne Kincaid, Przemyslaw Piechota, Emily Golden, Mikhail Maertens, Thomas Hartung, Alexandra Maertens. Using in silico tools to predict flame retardant metabolites for more informative exposomics-based approaches. Frontiers in Toxicology. 2023;5:1216802. doi:10.3389/ftox.2023.1216802
Anna J. van der Zalm, João Barroso, Patience Browne, et al. A framework for establishing scientific confidence in new approach methodologies. Archives of Toxicology. 2022;96:2865-2879. doi:10.1007/s00204-022-03365-4
Taha Messelmani, Lisa Morisseau, Yasuyuki Sakai, et al. Liver organ-on-chip models for toxicity studies and risk assessment. Lab on a Chip. 2022;22(13):2423-2450. doi:10.1039/d2lc00307d
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
Sebastian Hoffmann, Paul Whaley, Katya Tsaioun. How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessment. ALTEX. 2022;39(2):175-182. doi:10.14573/altex.2201131
Stanley T. Parish, Michael Aschner, Warren Casey, et al. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regulatory Toxicology and Pharmacology. 2020;112:104592. doi:10.1016/j.yrtph.2020.104592
A. Jain, R. Barrile, A. D. van der Meer, et al. Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics. Clinical Pharmacology and Therapeutics. 2018;103(2):332-340. doi:10.1002/cpt.742
Riccardo Barrile, Andries D. van der Meer, Hyoungshin Park, et al. Organ-on-Chip Recapitulates Thrombosis Induced by an anti-CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems. Clinical Pharmacology and Therapeutics. 2018;104(6):1240-1248. doi:10.1002/cpt.1054